Singapore's HSA to vet Sinovac vaccine before public roll-out

Singapore

A CORONAVIRUS vaccine developed by China's Sinovac Biotech will have to go through regulatory scrutiny and authorisation by Singapore's Health Sciences Authority (HSA) before it can be rolled out to the public, Health Minister Gan Kim Yong said on Wednesday.

This update follows the release of data on a Brazili…

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

Sign UpVIEW ALL